VOGALENE LYOC 7.5 mg, lyophilizate oral 16 oral lyophilisates
Active ingredients: Metopimazine
Commercialized according to BDPMDispensing in France: Prescription only
Lyophilizate16 oral lyophilisatesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VOGALENE LYOC 7,5 mg, lyophilisat oral
- Pharmaceutical form
- lyophilisat
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 16 lyophilisat(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jul 1993
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68318931CIP73331625CIP133400933316259Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTOPIMAZINElyophilisat | 7,50 mg · un lyophilisat | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.